Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70

• Chieh-Sheng Lu ,

  * E-mail: chengsem@gmail.com (CSL); hochingliang@yahoo.com.tw (CLH)

  Affiliations Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Ping-Ying Chang,

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Yu-Guang Chen,

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Jia-Hong Chen,

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Yi-Ying Wu,

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Ching-Liang Ho

  * E-mail: chengsem@gmail.com (CSL); hochingliang@yahoo.com.tw (CLH)

  Affiliation Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯